Skip to main content
. 2020 Aug 26;20:808. doi: 10.1186/s12885-020-07314-1

Table 1.

Characteristics of patients with ICRB group D retinoblastoma underwent intravitreal chemotherapy-assisted endoresection

No. Age (months) Vitreous seeds Classificationa Subretinal seeds Retinal detachment TMN Classificationb Treatment history
01 36 Dust Y Y cT2bN0M0H1 IVC + IViC
02 48 Dust Y Y cT2bN0M0H1 IVC + IViC
03 8 Dust Y N cT2bN0M0H1 IVC + IViC
04 30 Dust Y N cT2bN0M0H1 IVC + IViC
05 24 Dust Y N cT2bN0M0H1 IVC + IViC
06 78 Dust Y N cT2bN0M0H1 IVC + IViC
07 71 Dust Y N cT2bN0M0H1 IVC + IViC
08 65 Cloud Y N cT2bN0M0H1 IVC + IViC
09 88 Cloud Y Y cT2bN0M0H1 IVC + IViC
10 31 Spheres Y N cT2bN0M0H1 IVC + IAC + IViC
11 29 Spheres Y Y cT2bN0M0H1 IVC + IViC

IVC Intravenous chemotherapy, IViC Intravitreal chemotherapy, IAC Intra-arterial chemotherapy

aVitreous seeding was classified by the criteria of Francis, J. H. et al. [11]

bAccording to the 8th edition American Joint Committee on Cancer/Union for International Cancer Control Clinical Staging System (8th ed. cTNMH)